References 1. Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71: 435–471. 2. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729–777. 3. Lin X (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131: 6009–6021. 4. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154–156. 5. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78: 7634–7638. 6. Keller G (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19: 1129–1155. 7. Chambers I, Smith A (2004) Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23: 7150–7160. 8. Boiani M, Scholer HR (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6: 872–884. 9. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, et al. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336: 688–690. 10. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684–687. 11. Niwa H, Burdon T, Chambers I, Smith A (1998) Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12: 2048– 2060. 12. Niwa H (2007) How is pluripotency determined and maintained? Development 134: 635–646. 13. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643–655. 14. Ying QL, Nichols J, Chambers I, Smith A (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281–292. 15. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55–63. 16. Sasaki N, Okishio K, Ui-Tei K, Saigo K, Kinoshita-Toyoda A, et al. (2008) Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. J Biol Chem 283: 3594–3606. 17. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, et al. (2007) Wnt/b-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 104: 5668–5673. 18. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, et al. (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134: 2895–2902. 19. Sasaki N, Hirano T, Ichimiya T, Wakao M, Hirano K, et al. (2009) The 39- phosphoadenosine 59-phosphosulfate transporters, PAPST1 and 2, contribute to the maintenance and differentiation of mouse embryonic stem cells. PLoS One 4: e8262. 20. Kraushaar DC, Yamaguchi Y, Wang L (2010) Heparan sulfate is required for embryonic stem cells to exit from self-renewal. J Biol Chem 285: 5907–5916. 21. Lanner F, Lee KL, Sohl M, Holmborn K, Yang H, et al. (2010) Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state. Stem Cells 28: 191–200. 22. Johnson CE, Crawford BE, Stavridis M, Ten Dam G, Wat AL, et al. (2007) Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells 25: 1913–1923. 23. Baldwin RJ, ten Dam GB, van Kuppevelt TH, Lacaud G, Gallagher JT, et al. (2008) A developmentally regulated heparan sulfate epitope defines a HS4C3-Binding Epitope Contributes to Fas Signaling subpopulation with increased blood potential during mesodermal differentiation. Stem Cells 26: 3108–3118. 24. Ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, et al. (2006) 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem 281: 4654–4662. 25. Mochizuki H, Yoshida K, Shibata Y, Kimata K (2008) Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution. J Biol Chem 283: 31237–31245. 26. Xia G, Chen J, Tiwari V, Ju W, Li JP, et al. (2002) Heparan sulfate 3-O- sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem 277: 37912–37919. 27. Kamiyama S, Sasaki N, Goda E, Ui-Tei K, Saigo K, et al. (2006) Molecular cloning and characterization of a novel 39-phosphoadenosine 59-phosphosulfate transporter, PAPST2. J Biol Chem 281: 10945–10953. 28. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 90: 8424–8428. 29. Smith AG, Hooper ML (1987) Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 121: 1–9. 30. Smits NC, Lensen JF, Wijnhoven TJ, Ten Dam GB, Jenniskens GJ, et al. (2006) Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Methods Enzymol 416: 61–87. 31. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273: 12960–12966. 32. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, et al. (1998) Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282: 290–293. 33. Ko YG, Lee JS, Kang YS, Ahn JH, Seo JS (1999) TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. J Immunol 162: 7217–7223. 34. Legembre P, Moreau P, Daburon S, Moreau JF, Taupin JL (2002) Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas. Cell Death Differ 9: 329–339. 35. Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K (2003) Resistance of cell membranes to different detergents. Proc Natl Acad Sci U S A 100: 5795– 5800. 36. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, et al. (2002) Post- translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418: 417–422. 37. Duval D, Malaise M, Reinhardt B, Kedinger C, Boeuf H (2004) A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death Differ 11: 331–341. 38. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, et al. (2008) Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2: 595–601. 39. Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, et al. (2004) Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med 200: 353–365. 40. Schutze S, Tchikov V, Schneider-Brachert W (2008) Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 9: 655–662. 41. Ivanov VN, Lopez Bergami P, Maulit G, Sato TA, Sassoon D, et al. (2003) FAP- 1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol Cell Biol 23: 3623–3635. 42. Villena J, Mainez J, Noguer O, Contreras H, Granes F, et al. (2006) Syndecan-2 expression increases serum-withdrawal-induced apoptosis, mediated by re- distribution of Fas into lipid rafts, in stably transfected Swiss 3T3 cells. Apoptosis 11: 2065–2075. 43. Brunlid G, Pruszak J, Holmes B, Isacson O, Sonntag KC (2007) Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system. Stem Cells 25: 2551–2558. PLOS ONE | www.plosone.org 15 August 2012 | Volume 7 | Issue 8 | e43440